Refresher Courses: Oncologic Imaging

RC 516 - Ovarian cancer: where are we now?

March 2, 15:00 - 16:00 CET

RC 516-1
5 min
Chairperson's introduction
Rosemarie Forstner, Salzburg / Austria
RC 516-2
15 min
Radiologic impact on surgery management in ovarian cancer
Stefania Rizzo, Lugano / Switzerland
1. To list the appropriate imaging modalities and protocols.
2. To name and identify the sites of peritoneal carcinomatosis.
3. To summarise the information needed by surgeons in a structured report.
RC 516-3
15 min
FDG-PET in ovarian cancer
Hebert Alberto Vargas, New York, NY / United States
1. To understand the principles of FDG PET/CT as applied to ovarian cancer and to learn about the ovarian cancer clinical states in which FDG PET/CT demonstrates utility.
2. To discuss the role of PET/CT compared with other modalities used in ovarian cancer detection including CT and MRI.
3. To introduce novel uses of PET/CT including new imaging probes, machine learning, and artificial intelligence.
RC 516-4
15 min
Radiomics promises in ovarian cancer management
Evis Sala, Cambridge / UK
1. To illustrate the limitations of conventional imaging in the evaluation of treatment response and phenotypic heterogeneity in ovarian cancer.
2. To discuss the role of radiomics in unravelling tumour heterogeneity and predicting platinum resistance.
3. To understand the role of multi-omics data integration in refining treatment response assessment and outcome prediction.
RC 516-5
10 min
Panel discussion: What is the future of imaging ovarian cancer?

Moderators

Moderator

Rosemarie Forstner

Salzburg, Austria

Speakers

Presenter

Rosemarie Forstner

Salzburg, Austria

Presenter

Stefania Rizzo

Lugano, Switzerland

Presenter

Hebert Alberto Vargas

New York, United States

Presenter

Evis Sala

Cambridge, United Kingdom